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Summary 
 
Two hundred forty-six commercial Angus-
based cows were used to determine the effect 
of adding Aureomycin® for anaplasmosis con-
trol or Rumensin® to mineral supplements on 
summer beef cowherd performance.  Cow/calf 
pairs were randomly allotted to summer na-
tive-pasture groups by treatment, and were fed 
an industry-standard mineral/trace mineral 
supplement for the duration of the trial.  The 
study had three treatments:  (1) control min-
eral supplement with no medication added, (2) 
the same base supplement with the addition of 
Aureomycin® (0.5 mg/lb cow body weight 
daily), and (3) the base supplement with the 
addition of Rumensin® (200 mg/cow daily).  
Feed additives were blended into the mineral 
mix to provide the targeted daily consumption. 
Treatments were initiated May 6 and main-
tained through October 6. Mineral intake was 
similar among treatments. Cow and calf 
weight gains were similar among treatments 
during the first 32 days of the study.  By the 
trial end, there were no significant differences 
in cow body condition score gains and preg-
nancy rates.  Total calf gains for the duration 
of the trial were similar for groups supple-
mented with Aureomycin®, and Rumensin®, 
and both were greater than for control calves 
(21 and 18 lb greater, respectively).  Overall 
herd health was enhanced by feeding Aureo-
mycin® when compared with control or Ru-
mensin®.  Foot rot was the main health con-
cern in this trial, and the addition of Aureo-
mycin® to mineral supplements reduced foot 
rot.                
 
Introduction 
 
Mineral supplementation is an important 
practice for cow/calf operations to meet cow 
mineral requirements during the summer graz-
ing periods.  Lack of specific minerals can de-
crease cow weights, calf gains, and reproduc-
tive rates.  Still, the addition of medicated 
mineral premixes over and above standard 
mineral packages has the benefit of increasing 
cowherd performance and weight gains while 
reducing herd health concerns.  The objective 
of this study was to determine the effects of 
medicated mineral supplements on cow and 
calf weights, cow body condition scores, and 
incidence of sickness compared with perform-
ance of a standard mineral supplement.       
 
Procedures 
 
Two hundred forty-six commercial Angus-
based cow/calf pairs were randomly allotted to 
three treatment groups that were balanced for 
dam and calf age.  Cows were weighed and 
body condition scored April 26 to establish 
baseline measures.  On May 6, cows and 
calves were weighed, cows were body condi-
tion scored, and then pairs were sorted into 
treatment pastures.  Pasture groups were allot-
ted randomly to treatments.  All cattle grazed 
native pastures with water available at all 
times. Cattle were rotated among the pastures 
on a 2- to 4-week schedule.  A standard min-
eral/trace mineral supplement was provided to 
all pastures throughout the duration of the 
trial.  All treatments were administered in an 
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industry-standard mineral supplement. Treat-
ments were:  (1) control mineral supplement 
with no medication added, (2) the same base 
supplement with the addition of Aureomy-
cin®-90 (chlortetracycline HCl, 0.5 mg/lb 
body weight) for anaplasmosis control, and (3) 
the base supplement with the addition of Ru-
mensin® (monensin sodium, 200 mg/cow 
daily).  All cattle had free-choice access to 
mineral feeders throughout the trial.  Mineral 
supplement consumption was monitored 
weekly, orts were recorded, and concentra-
tions of medications were maintained to pro-
vide the designated amounts.  On October 5, 
cows were weighed and body condition 
scored, and calf weaning weight was recorded.  
Cow weights, gains, body condition scores, 
and pregnancy rates were measured.  Cow 
weight and condition scores were measured at 
the beginning of the trial, immediately before 
the breeding season, and on the weaning date.  
Cow/calf pairs were gathered in the late after-
noon one day before measuring cattle weights, 
and were fed 10 lb/pair of prairie hay in dry-
lots with no access to water.  Cows and calves 
were separated just before weighing and body 
condition scoring, which began early the next 
morning.  Body condition (scale 1 to 9, 
1=emaciated, 9=obese) was determined by 
averaging the estimates obtained from four 
independent observers.  Observers used both 
visual and palpation techniques to determine 
their score.  
 
Blood samples were collected May 16 and 
May 26 to determine the percentage of cows 
cycling before estrous synchronization and 
breeding.  Estrous synchronization consisted 
of two shots of PGF2α, on May 26 and June 6, 
to initiate the breeding season.  Cows were 
artificially inseminated to three purebred An-
gus bulls from June 7 through June 11 by us-
ing heat detection and the AM/PM rule.  
Polled Hereford bulls were then turned out on 
June 15 for natural service.  Natural breeding 
season lasted 65 days.  Pregnancy confirma-
tion by rectal palpation occurred from October 
14 to October 22. 
In addition, cow and calf incidence of bo-
vine respiratory disease, foot rot, pinkeye, and 
general health concerns for cattle were meas-
ured throughout the study.  Sickness, health 
treatments, and mortality records were kept on 
the entire herd.  Cows and calves were vacci-
nated and processed according to a protocol 
designed by our consulting veterinarian. 
 
Results and Discussion 
 
Daily mineral consumption was between 
4.4 and 5.2 ounces per cow/calf pair (Table 1).  
Mineral intake was similar among treatments, 
but, numerically the Rumensin®-containing 
mineral was consumed in lesser amounts than 
the other mineral mixes.  Mineral intake re-
mained fairly constant from the beginning to 
the end of the trial.  Rumensin® intake aver-
aged 216 mg per cow/calf pair daily.  Aureo-
mycin® intake averaged 910 mg per cow/calf 
pair daily.  The average weight of the cows 
fed Aureomycin® was 1084 lbs.  Therefore, 
cows consumed an average of 0.84 mg 
Aureomycin®/lb body weight throughout the 
trial.   
 
Table 2 lists the weights, body condition 
scores, and pregnancy rate of the cows.  It is 
remarkable that cows gained nearly 3.7 lb/day 
during the first 32 days of the trial.  These 
dates correspond to the 32 days before the 
start of the breeding season.  Much of the 
weight gain can be attributed to gut fill as pas-
ture quality improved over this period due to 
warming temperatures and rainfall (May 
2004).  Cow and calf weight gains were simi-
lar among treatments during the first 32 days 
of the experiment.  During the first 32 days, 
cows fed Rumensin® gained about 0.1 body 
condition score more than did cows fed 
Aureomycin®.  By weaning time, however, all 
treatments showed similar gains in body con-
dition score.  Body condition scores remained 
similar between treatments throughout the 
trial.  Pregnancy rates were similar between 
treatments, ranging from 88.9 to 92.0%. 
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Calf gains were similar among treatments 
during the first 32 days of the trial (Table 2).  
Total calf gains for the duration of the ex-
periment were similar for calves of cows sup-
plemented with Aureomycin® and Rumensin®, 
and both were greater than gains of control 
calves (21 and 18 lb greater, respectively).     
 
Table 3 shows the herd health data.  Herd 
health was improved by feeding Aureomy-
cin®, compared with the control or Rumen-
sin®.  The most common illness detected and 
treated was foot rot.  Pinkeye and respiratory 
diseases were minimal throughout the trial 
period.  Combining all categories of illness, 
cattle fed Aureomycin® incurred fewer bouts 
of sickness.   
 
Addition of either Aureomycin® or Ru-
mensin® to mineral supplements fed to 
cow/calf pairs grazing summer pastures will 
increase calf weaning weights without sacri-
ficing cowherd weight, body condition, or re-
productive rates.  The addition of Aureomy-
cin® to mineral supplements reduced the inci-
dence of foot rot.  This can lead to substantial 
savings in medical costs, labor costs, and ani-
mal handling.   
 
 
Table 1.  Average Intake of Mineral Mixes Used in Experiment 
 Treatment 
Item Control Aureomycin® Rumensin® 
No. of cow/calf pairs 62  91 93 
No. of pasture groups   2   3   3 
Mineral intake, oz/pair daily      4.9      5.2      4.4 
Medication intake, mg/pair daily   0            910            216 
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Table 2. Effects of Mineral Medication Treatments on Cowherd Performance 
 Treatment  Contrast P-value 
Item Control Aureomycin® Rumensin®
Control 
vs. 
Medicated 
Aureomycin® 
vs. 
Rumensin® 
Initial cow wt, lb 1013 977 981   
Initial BCSa  5.0 4.9 4.9   
Initial calf wt, lb  218 219 218   
Start of Trial to Beginning of Breeding Season (32 days) 
   Cow breeding wt, lb  1109 1098 1108 0.25 0.07 
   Cow breeding BCS  5.0 5.0 5.1 0.52 0.19 
   Calf wt, lb  301 302 302 0.82 0.73 
   Cow wt gain, lb  121 114 120 0.61 0.32 
   Cow BCS change  0.15 0.18 0.30 0.08 0.03 
   Calf wt gain, lb 83 84 83 0.87 0.45 
Start of Trial to Weaning (152 days) 
   Cow Weaning wt, lb 1194 1181 1180 0.14 0.95 
   Cow Weaning BCS  5.1 5.1 5.0 0.40 0.18 
   Calf weaning wt, lb  561 579 581 0.0002 0.74 
   Cow wt gain, lb  206 198 192 0.28 0.60 
   Cow BCS change  0.2 0.2 0.2 0.52 0.98 
   Calf wt gain, lb  343 362 362 0.0001 0.97 
Pregnancy rate, %  90.2 92.0 88.9 0.95 0.49 
aBody condition score, estimated on a scale of 1 = emaciated to 9 = obese. 
 
 
Table 3. Effect of Mineral Medication Treatments on Incidence of Cowherd Health 
Problems 
 Treatment  
Item Control Aureomycin® Rumensin® P-value 
No. of cows and calves 124 182 184  
 ------ Percentage of Cattle Treated for Illness ------  
Foot rot 21.0 6.6 19.4     0.0006 
Repull for foot rot 22.2 8.3 26.3 0.08 
Pink eye 0.8 0.0 0.5 0.99 
Respiratory diseases 0.0 0.0 0.5 0.99 
All illnesses  21.8 6.6 20.4     0.0003 
  
 
